公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2021 | Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC | Awad M.M.; Gadgeel S.M.; Borghaei H.; Patnaik A.; CHIH-HSIN YANG ; Powell S.F.; Gentzler R.D.; Martins R.G.; Stevenson J.P.; Altan M.; Jalal S.I.; Panwalkar A.; Gubens M.; Sequist L.V.; Saraf S.; Zhao B.; Piperdi B.; Langer C.J. | Journal of Thoracic Oncology | 94 | 77 | |
2020 | Pembrolizumab or placebo plus etoposide and platinum as first-line therapy for extensive-stage small-cell lung cancer: Randomized, double-blind, phase III KEYNOTE-604 Study | Rudin C.M.; Awad M.M.; Navarro A.; Gottfried M.; Peters S.; Csoszi T.; Cheema P.K.; Rodriguez-Abreu D.; Wollner M.; CHIH-HSIN YANG ; Mazieres J.; Orlandi F.J.; Luft A.; G?m?? M.; Kato T.; Kalemkerian G.P.; Luo Y.; Ebiana V.; Pietanza M.C.; Kim H.R.; KEYNOTE-604 Investigators | Journal of Clinical Oncology | 389 | 303 | |
2017 | Targeting RET in patients with RET-rearranged lung cancers: Results from the global, multicenter RET registry | Gautschi O.; Milia J.; Filleron T.; Wolf J.; Carbone D.P.; Owen D.; Camidge R.; Narayanan V.; Doebele R.C.; Besse B.; Remon-Masip J.; Janne P.A.; Awad M.M.; Peled N.; Byoung C.-C.; Karp D.D.; Van Den Heuvel M.; Wakelee H.A.; Neal J.W.; Mok T.S.K.; CHIH-HSIN YANG ; Ou S.-H.I.; Pall G.; Froesch P.; Zalcman G.; Gandara D.R.; Riess J.W.; Velcheti V.; Zeidler K.; Diebold J.; Früh M.; Michels S.; Monnet I.; Popat S.; Rosell R.; Karachaliou N.; Rothschild S.I.; JIN-YUAN SHIH ; Warth A.; Muley T.; Cabillic F.; Mazières J.; Drilon A. | Journal of Clinical Oncology | 279 | 249 |